Heme polymerization in Plasmodium

Heme polymerization in Plasmodium refers to a critical detoxification process by which the malaria parasite converts toxic free heme, released during digestion of host hemoglobin within its digestive vacuole, into an inert crystalline form called hemozoin (β-hematin)[1][2][3][4]. This process is essential for parasite survival, as free heme is cytotoxic and generates reactive oxygen species that could otherwise result in parasite and host cell death[2][4]. Multiple molecular pathways may contribute to hemozoin formation, including catalysis by parasite-derived proteins (such as histidine-rich proteins and heme detoxification protein), as well as lipid-mediated, autocatalytic, and physicochemical mechanisms[1][4][6]. Drugs that inhibit heme polymerization (such as chloroquine and artemisinin derivatives) prevent the detoxification of free heme, causing accumulation of toxic heme or formation of heme-drug complexes, ultimately killing the parasite[3][4][7]. The inhibition of hemozoin formation is a clinically validated antimalarial drug target and plays a central role in malaria pathogenesis and treatment[4][5][7]. However, "heme polymerization in Plasmodium" describes a biochemical process, not a single molecule or traditional receptor/target, so the entry is not a canonical protein target but a validated pathway/process.

Other names

Hemozoin formationβ-hematin formationHeme detoxification pathwayMalaria pigment formation

Inhibiting polymerization of free heme into nontoxic hemozoin, leading to accumulation of toxic free heme which damages Plasmodium[2][3][4][5][7]. Formation of heme-drug complexes which are parasiticidal[4]. Disruption of digestive vacuole pH, lipid, and protein profile by interfering with hemozoin formation[6].